AtriCure Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 24.8% | 25.8% | 26.0% | 26.0% | 25.1% | 25.5% | 25.1% | 25.5% | 24.5% | 25.6% | 22.6% | 22.8% | 23.8% | |
| 75.2% | 74.2% | 74.0% | 74.0% | 74.9% | 74.5% | 74.9% | 74.5% | 75.5% | 74.4% | 77.4% | 77.2% | 76.2% | |
| 20.7% | 19.5% | 18.2% | 16.9% | 18.1% | 28.1% | 18.2% | 21.5% | 17.0% | 16.2% | 17.2% | 17.2% | 16.9% | |
| 62.7% | 63.5% | 66.5% | 63.3% | 63.2% | 58.1% | 61.5% | 57.6% | 58.3% | 55.8% | 59.9% | 53.7% | 56.8% | |
| 83.4% | 82.4% | 84.0% | 80.2% | 81.3% | 86.2% | 79.7% | 79.1% | 75.3% | 71.9% | 77.0% | 70.9% | 73.7% | |
| -8.2% | -8.1% | -10.0% | -6.2% | -6.4% | -11.7% | -4.8% | -4.5% | 0.2% | 2.5% | 0.4% | 6.3% | 2.4% | |
| 1.8% | 1.7% | 1.5% | 1.4% | 1.4% | 1.2% | 1.1% | 1.1% | 2.2% | 1.1% | 0.9% | 0.9% | 1.2% | |
| -9.2% | -8.8% | -12.0% | -6.7% | -6.5% | -12.3% | -5.3% | -4.4% | -0.1% | 1.7% | 0.3% | 6.1% | 2.1% | |
| 0.0% | 0.4% | 0.2% | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.1% | 0.4% | 0.2% | 0.3% | 0.3% | |
| -9.2% | -9.2% | -12.2% | -6.9% | -6.8% | -12.5% | -5.5% | -4.5% | -0.2% | 1.2% | 0.1% | 5.8% | 1.9% | |
| -3.2% | -3.2% | -6.4% | -1.4% | -0.8% | -7.3% | 0.0% | 0.5% | 5.9% | 6.4% | 5.0% | 2.1% | 4.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.